NYSE:AVTR - Avantor Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $35.19
  • Forecasted Upside: 0.08 %
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.09 (-0.26%)

This chart shows the closing price for AVTR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Avantor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVTR

Analyst Price Target is $35.19
▲ +0.08% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Avantor in the last 3 months. The average price target is $35.19, with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 0.08% upside from the last price of $35.16.

This chart shows the closing price for AVTR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 14 contributing investment analysts is to buy stock in Avantor. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 21 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 22 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 16 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/4/2021The Goldman Sachs GroupInitiated CoverageBuy$40.00Medium
4/29/2021Credit Suisse GroupBoost Price TargetOutperform$37.00 ➝ $39.00Low
4/29/2021Raymond JamesBoost Price TargetOutperform$34.00 ➝ $37.00High
4/29/2021Morgan StanleyBoost Price TargetOverweight$35.00 ➝ $38.00High
4/29/2021JPMorgan Chase & Co.Boost Price TargetOverweight$35.00 ➝ $40.00High
4/29/2021Robert W. BairdBoost Price TargetOutperform$32.00 ➝ $36.00High
4/29/2021Piper SandlerBoost Price TargetNeutral$28.00 ➝ $32.00High
4/29/2021Stifel NicolausUpgradeHold ➝ Buy$40.00High
3/8/2021BarclaysInitiated CoverageOverweight$33.00N/A
3/2/2021BarclaysInitiated CoverageOverweight$33.00Medium
2/4/2021CitigroupBoost Price Target$33.00 ➝ $35.00Medium
2/4/2021Credit Suisse GroupBoost Price TargetOutperform$33.00 ➝ $34.00Low
2/4/2021Morgan StanleyBoost Price TargetOverweight$27.00 ➝ $35.00Medium
2/4/2021Piper SandlerBoost Price TargetNeutral$21.00 ➝ $28.00Medium
1/19/2021KeyCorpBoost Price TargetOverweight$33.00 ➝ $40.00Low
1/12/2021Raymond JamesBoost Price TargetOutperform$30.00 ➝ $34.00Medium
12/16/2020Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$28.00 ➝ $33.00Medium
12/16/2020Smith Barney CitigroupBoost Price Target$28.00 ➝ $33.00Low
11/9/2020KeyCorpUpgradeSector Weight ➝ Overweight$33.00High
10/30/2020Smith Barney CitigroupBoost Price Target$24.00 ➝ $28.00Medium
10/29/2020JPMorgan Chase & Co.Boost Price TargetOverweight$25.00 ➝ $28.00Medium
10/29/2020Morgan StanleyBoost Price TargetOverweight$24.00 ➝ $27.00Low
10/29/2020Robert W. BairdBoost Price TargetOutperform$23.00 ➝ $27.00Low
10/28/2020Wells Fargo & CompanyBoost Price TargetOverweight$23.00 ➝ $28.00High
10/12/2020Raymond JamesBoost Price TargetOutperform$23.00 ➝ $27.00Low
10/9/2020Jefferies Financial GroupBoost Price TargetBuy$25.00 ➝ $30.00Low
9/14/2020Morgan StanleyInitiated CoverageOverweight$24.00Medium
8/3/2020Truist FinancialBoost Price TargetBuy$21.00 ➝ $29.00Medium
7/30/2020Stifel NicolausBoost Price TargetHold$18.00 ➝ $21.50High
7/30/2020Raymond JamesBoost Price TargetOutperform$17.00 ➝ $23.00Low
7/30/2020JPMorgan Chase & Co.Boost Price TargetOverweight$18.00 ➝ $25.00High
7/30/2020Piper SandlerBoost Price TargetNeutral$16.00 ➝ $21.00High
7/28/2020Credit Suisse GroupBoost Price TargetOutperform$18.00 ➝ $21.00Medium
7/15/2020Cleveland ResearchUpgradeNeutral ➝ BuyHigh
4/30/2020CSFBLower Price TargetOutperform$20.00 ➝ $18.00Low
4/30/2020Credit Suisse GroupLower Price TargetOutperform$20.00 ➝ $18.00Medium
4/30/2020CitigroupBoost Price TargetBuy$16.00 ➝ $19.00Medium
4/30/2020Stifel NicolausBoost Price TargetHold$15.00 ➝ $18.00High
4/30/2020Raymond JamesLower Price TargetOutperform$19.00 ➝ $17.00High
4/28/2020UBS GroupLower Price TargetBuy$22.00 ➝ $20.00High
4/2/2020Stifel NicolausLower Price TargetHold$16.00 ➝ $15.00Medium
3/26/2020BarclaysLower Price TargetOverweight$21.00 ➝ $19.00Medium
3/20/2020CitigroupLower Price TargetBuy$22.00 ➝ $11.00High
2/10/2020Raymond JamesLower Price TargetOutperform$20.00 ➝ $19.00High
2/7/2020CowenReiterated RatingBuy$23.00High
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$22.00Medium
1/7/2020CitigroupInitiated CoverageBuy$21.00High
11/14/2019Stifel NicolausInitiated CoverageHoldLow
11/5/2019Piper Jaffray CompaniesLower Price TargetNeutral$17.00 ➝ $15.00High
8/2/2019Cleveland ResearchInitiated CoverageNeutral ➝ NeutralHigh
7/18/2019BarclaysReiterated RatingBuy$22.00Medium
6/26/2019Janney Montgomery ScottReiterated RatingBuy$27.00 ➝ $18.70Low
6/14/2019Janney Montgomery ScottInitiated CoverageBuyLow
6/12/2019Raymond JamesInitiated CoverageOutperform$20.00High
6/11/2019GuggenheimInitiated CoverageBuy ➝ Buy$21.00Low
6/11/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$22.00Low
6/11/2019Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$22.00Low
6/11/2019Evercore ISIInitiated CoverageOutperform ➝ Outperform$23.00Low
6/11/2019Jefferies Financial GroupInitiated CoverageBuy ➝ BuyMedium
6/11/2019Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$20.00Medium
6/11/2019Robert W. BairdInitiated CoverageOutperform ➝ Outperform$20.00High
6/11/2019William BlairInitiated CoverageOutperform ➝ OutperformHigh
6/11/2019KeyCorpInitiated CoverageSector Weight ➝ Sector WeightMedium
6/11/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$22.00Medium
6/11/2019CitigroupInitiated CoverageBuy ➝ Buy$21.00Medium
6/11/2019BarclaysInitiated CoverageOverweight ➝ Overweight$20.00Medium
6/11/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$21.00Medium
6/11/2019CowenInitiated CoverageOutperform ➝ Outperform$21.00Medium
6/11/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$20.00Medium
6/11/2019UBS GroupInitiated CoverageBuy ➝ Buy$21.00Medium
6/11/2019The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$20.00 ➝ $20.00Medium
6/11/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$19.00Medium
(Data available from 6/24/2016 forward)
Avantor logo
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, and clinical trial kits. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Read More

Today's Range

Now: $35.16
Low: $35.12
High: $35.62

50 Day Range

MA: $32.19
Low: $30.08
High: $35.25

52 Week Range

Now: $35.16
Low: $16.44
High: $35.62


3,210,624 shs

Average Volume

4,300,083 shs

Market Capitalization

$20.47 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Avantor?

The following sell-side analysts have issued stock ratings on Avantor in the last twelve months: Barclays PLC, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cleveland Research, Credit Suisse Group AG, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Morgan Stanley, Piper Sandler, Raymond James, Robert W. Baird, Smith Barney Citigroup, Stifel Nicolaus, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., Wells Fargo & Company, and Zacks Investment Research.
View the latest analyst ratings for AVTR.

What is the current price target for Avantor?

16 Wall Street analysts have set twelve-month price targets for Avantor in the last year. Their average twelve-month price target is $35.19, suggesting a possible upside of 0.1%. The Goldman Sachs Group, Inc. has the highest price target set, predicting AVTR will reach $40.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $28.00 for Avantor in the next year.
View the latest price targets for AVTR.

What is the current consensus analyst rating for Avantor?

Avantor currently has 1 hold rating and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AVTR will outperform the market and that investors should add to their positions of Avantor.
View the latest ratings for AVTR.

What other companies compete with Avantor?

How do I contact Avantor's investor relations team?

Avantor's physical mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company's listed phone number is 610-386-1700 and its investor relations email address is [email protected] The official website for Avantor is www.avantorsciences.com.